Bowery Valuation
The first tech-enabled commercial appraisal firm
109 employees · est. 2016 · New York, United States
MYCB1 Group B.V.
MYCB1 Group B.V. produces, and distributes GMP-grade cannabinoid medicines via its German subsidiary, MYCB1 GmbH
18 employees · est. 2017 · Amsterdam, The Netherlands
Bowery Valuation is the older company (2016 vs 2017); Bowery Valuation is the larger of the two.
Side-by-Side Comparison
| Metric | Bowery Valuation | MYCB1 Group B.V. |
|---|---|---|
| Founded | ||
| Founded | 2016 older | 2017 |
| Headquarters | ||
| Headquarters | New York, United States | Amsterdam, The Netherlands |
| Employees | ||
| Employees | 109 larger | 18 |
| Industry | ||
| Industry | Productivity, Real Estate, SaaS | AI, Health Care, Medical Devices |
| Funding Stage | ||
| Funding Stage | Series B | Debt Financing |
| Total Funding | ||
| Total Funding | $78.05M | $3.11M |
| Funding Rounds | ||
| Funding Rounds | 7 | 3 |
| Services | ||
| Services | Not tracked yet | regulatory infrastructure support, GMP/GDP operations, storage services, distribution services, brand retention services, curated product portfolio |
| Target Customers | ||
| Target Customers | Not tracked yet | pharmaceutical companies, cannabis brands, healthcare distributors |
| Taxonomy | ||
| Taxonomy | Commercial Appraisal, Tech-enabled Appraisal, Big Data, Advanced Technology, Proprietary Platform, Venture Capital-backed, Cloud-based Software, Mobile Application, Appraisal Reports, Natural Language Generator | Cannabinoid Medicines, GMP-grade Pharmaceuticals, Pharmaceutical Manufacturing, Prescription-only Medications, Personalized Medicine, Digital Health Solutions, Generative AI, Real-World Evidence, Patient-Centric Healthcare, Data-Driven Health Decisions, Health Technology Scale-up, Evidence-Based Healthcare, Software Engineering In Health, Pharmacy Operations |
| Website | ||
| Website | boweryvaluation.com | mycb1.de |
About Bowery Valuation
Bowery Valuation is redefining the commercial appraisal space through big data, advanced technology, and extensive expertise. Their proprietary platform allows appraisers to work smarter and faster, delivering unparalleled accuracy and consistency in record time. Founded in 2016, Bowery has position...
About MYCB1 Group B.V.
MYCB1 Group B.V. is a Dutch pharmaceutical group that stands out for its specialization in cannabinoid-based medical solutions. Its subsidiary, MYCB1 GmbH in Steinheim, Westphalia, serves as the core of its operations, focusing on the production and distribution of GMP-grade cannabinoid medicines....
We will tell you when either one moves
BounceWatch watches Bowery Valuation and MYCB1 Group B.V. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Bowery Valuation and MYCB1 Group B.V. — by email.
Frequently Asked Questions
Compare Bowery Valuation with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Bowery Valuation on 11 Sep 2024, and MYCB1 Group B.V. on 18 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.